Trial Profile
Phase I multiple-dose study of setrobuvir in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2009
Price :
$35
*
At a glance
- Drugs Setrobuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Anadys Pharmaceuticals
- 28 Apr 2009 Status changed to completed.
- 23 Apr 2009 Results are expected to be reported at a meeting later in 2009.
- 23 Apr 2009 New trial record.